News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Eli Lilly and Company (LLY) Reports Fourth-Quarter And Full-Year 2013 Results



1/30/2014 8:03:22 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

INDIANAPOLIS, Jan. 30, 2013 /PRNewswire/ --

-- Fourth-quarter 2013 revenue declined 2 percent driven by Cymbalta U.S. patent expiration, partially offset by growth in other products.

-- Fourth-quarter 2013 earnings per share were $0.67 (reported), or $0.74 (non-GAAP).

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES